| Name | Title | Contact Details |
|---|
The mission of New Mexico Department of Health is to promote health and wellness, improve health outcomes, and assure safety net services for all people in New Mexico.
Allure Healthcare Services is a healthcare company that provides skilled nursing, assisted living, and independent senior living communities with quality care and operations management.
Our mission—empowering our customers to achieve their best health—exemplifies our commitment to look at healthcare differently. But even more importantly, we look at you, the customer, differently. We believe that healthcare can be better and this is what really drives us. At North Memorial Health, you have a voice and we listen. You have health goals and we have the knowledge and the tools to help you get there. Even when illness or injury steals your strength, we will not let it steal your power. We believe when you`re engaged and informed, you will have better health and a better life.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
South Florida Baptist Hospital, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. South Florida Baptist Hospital, Inc is based in Plant City, FL. You can find more information on South Florida Baptist Hospital, Inc at www.sjbhealth.org